Zolpidem in Progressive Supranuclear Palsy

被引:11
作者
Dash, Sandip K. [1 ]
机构
[1] Apollo Hosp Dhaka, Dept Neurol, Basundhara R-A, Dhaka 1229, Bangladesh
关键词
D O I
10.1155/2013/250865
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disorder, characterized by motor symptoms, postural instability, personality changes, and cognitive impairment. There is no effective treatment for this disorder. Reduced neurotrans-mission of GABA in the striatum and globus pallidus may contribute to the symptoms of motor and cognitive symptoms seen in PSP. Zolpidem is a GABA agonist of the benzodiazepine subreceptor BZ1. Here a nondiabetic, normotensive case of PSP is (Progressive Supranuclear Palsy) described, which showed improvement in swallowing, speech, and gaze paresis after zolpidem therapy and possible mechanism of actions are discussed. However, more trials are needed with large number of patients to confirm the effectiveness of zolpidem in progressive supranuclear palsy.
引用
收藏
页数:2
相关论文
共 5 条
[1]   The use of zolpidem in the treatment of progressive supranuclear palsy [J].
Cotter, C. ;
Armytage, T. ;
Crimmins, D. .
JOURNAL OF CLINICAL NEUROSCIENCE, 2010, 17 (03) :385-386
[2]   Zolpidem in progressive supranuclear palsy [J].
Daniele, A ;
Moro, E ;
Bentivoglio, AR .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) :543-544
[3]   In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy [J].
Gerhard, A ;
Trender-Gerhard, I ;
Turkheimer, F ;
Quinn, NP ;
Bhatia, KP ;
Brooks, DJ .
MOVEMENT DISORDERS, 2006, 21 (01) :89-93
[4]   ALTERATIONS OF GABAERGIC NEURONS IN THE BASAL GANGLIA OF PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY - AN IN-SITU HYBRIDIZATION STUDY OF GAD(67) MESSENGER-RNA [J].
LEVY, R ;
RUBERG, M ;
HERRERO, MT ;
VILLARES, J ;
JAVOYAGID, F ;
AGID, Y ;
HIRSCH, EC .
NEUROLOGY, 1995, 45 (01) :127-134
[5]   Zolpidem in progressive supranuclear palsy [J].
Mayr, BJ ;
Bonelli, RN ;
Niederwieser, G ;
Költringer, P ;
Reisecker, F .
EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 (02) :184-185